SMTL ID : 3cwj.1 (1 other biounit)

Crystal structure of hcv ns5b polymerase with a novel pyridazinone inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

1 x 321: N-{3-[5-hydroxy-2-(3-methylbutyl)-3-oxo-6-thiophen-2-yl-2,3-dihydropyridazin-4-yl]-1,1-dioxido-2H-1,4-benzothiazin-7-yl}methanesulfonamide(Non-covalent)

321.1: 20 residues within 4Å: Chain A: F.193, P.197, R.200, S.288, N.291, N.316, G.317, D.318, C.366, S.368, L.384, G.410, N.411, M.414, Y.415, Q.446, I.447, Y.448, G.449, S.556 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:P.197, A:L.384, A:M.414, A:Y.448 Hydrogen bonds: A:N.291, A:D.318, A:D.318, A:Y.448 Water bridges: A:S.556 pi-Stacking: A:F.193, A:F.193

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ellis, D.A. et al., 4-(1,1-Dioxo-1,4-dihydro-1lambda6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-ones as potent inhibitors of HCV NS5B polymerase. Bioorg.Med.Chem.Lett. (2008)

Release Date

2009-04-21

Peptides

RNA-DIRECTED RNA POLYMERASE: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

RNA-DIRECTED RNA POLYMERASE

Related Entries With Identical Sequence